Literature DB >> 27365802

Supplemental oxygen therapy in bleomycin-induced pulmonary toxicity: REPLY.

J Debnath1.   

Abstract

Entities:  

Year:  2011        PMID： 27365802      PMCID： PMC4920756          DOI： 10.1016/S0377-1237(11)60037-3

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  6 in total

Review 1.  Perioperative considerations for patients treated with bleomycin.

Authors:  M I Waid-Jones; D B Coursin
Journal:  Chest       Date:  1991-04       Impact factor: 9.410

2.  Supplemental oxygen does not cause respiratory failure in bleomycin-treated surgical patients.

Authors:  K R LaMantia; J H Glick; B E Marshall
Journal:  Anesthesiology       Date:  1984-01       Impact factor: 7.892

3.  Carbon monoxide diffusing capacity is a poor predictor of clinically significant bleomycin lung. New Zealand Clinical Oncology Group.

Authors:  M J McKeage; B D Evans; C Atkinson; D Perez; G V Forgeson; P J Dady
Journal:  J Clin Oncol       Date:  1990-05       Impact factor: 44.544

Review 4.  Oxygen-exacerbated bleomycin pulmonary toxicity.

Authors:  T S Ingrassia; J H Ryu; V F Trastek; E C Rosenow
Journal:  Mayo Clin Proc       Date:  1991-02       Impact factor: 7.616

5.  Carbon monoxide diffusing capacity: a reliable indicator of bleomycin-induced pulmonary toxicity.

Authors:  P G Sørensen; N Rossing; M Rørth
Journal:  Eur J Respir Dis       Date:  1985-05

6.  Bleomycin associated pulmonary toxicity: is perioperative oxygen restriction necessary?

Authors:  S M Donat; D A Levy
Journal:  J Urol       Date:  1998-10       Impact factor: 7.450
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.